Asia-Pacific Journal of Clinical Oncology is an essential publication within the field of medical oncology, dedicated to advancing the understanding and treatment of cancer through rigorous research and innovative clinical practices. Published by WILEY, this journal has established itself as a significant resource for researchers, healthcare professionals, and students interested in the latest findings across the Asia-Pacific region and beyond. With a respectable impact factor and categorized within the Q2 and Q3 quartiles of Medicine (miscellaneous) and Oncology respectively, the journal aims to disseminate knowledge on diverse aspects of clinical oncology, promoting the improvement of patient care and treatment outcomes. The Asia-Pacific Journal of Clinical Oncology, operating from the United Kingdom, invites contributions that highlight significant findings and advancements in oncology, making it a crucial platform for collaboration and knowledge sharing in this vital field of medicine.

The JOURNAL OF CANCER EDUCATION, published by SPRINGER, stands as a pivotal resource in the fields of oncology and public health. With an ISSN of 0885-8195 and an E-ISSN of 1543-0154, this esteemed journal has been disseminating vital research since 1986 and continues to play a crucial role in advancing knowledge until 2024. Recognized in 2023 with a Q3 rating in Oncology and a Q2 rating in Public Health, it reflects a solid standing in an ever-evolving academic landscape. The journal ranks #297 out of 665 in the Public Health category and #233 out of 404 in Oncology, showcasing its contribution to the scientific community. Aimed at researchers, practitioners, and students alike, the journal invites submissions that enhance understanding of cancer education, prevention, and management, ensuring that the knowledge shared is both impactful and accessible. With its focus on evidence-based practices and innovative educational strategies in cancer care, the JOURNAL OF CANCER EDUCATION serves as an essential platform for fostering collaboration and progress in oncology education.

BMC Primary Care is a leading peer-reviewed journal published by BMC that provides a vital platform for the dissemination of research and developments in the field of primary care. Established in 2022 as an open access journal, it allows for greater accessibility and visibility of research findings. Operating from the United Kingdom, BMC Primary Care has rapidly assumed an esteemed position within the academic community, currently ranked in the Q1 category for both Family Practice and Medicine (miscellaneous) based on 2023 metrics. With a Scopus rank of #9 out of 56 in Family Practice, positioned in the 84th percentile, this journal serves as an essential resource for researchers, healthcare practitioners, and students seeking to enhance their understanding of primary care dynamics. Through a commitment to high-quality research, BMC Primary Care aims to foster innovation and effective practices that ultimately improve patient care and health outcomes.

CANCER, published by Wiley, stands as a pivotal journal in the field of oncology and cancer research, boasting an impressive impact factor and consistently dynamic growth since its inception in 1948. With an ISSN of 0008-543X and an E-ISSN of 1097-0142, this esteemed journal is recognized for its rigorous peer-reviewed articles, making significant contributions to the understanding of cancer biology, treatment modalities, and clinical practices. CANCER holds a distinguished position in the academic community, securing its placement in the Q1 category for both cancer research and oncology, and ranks within the top percentiles on Scopus, indicating its high impact and relevance. The journal is particularly beneficial for researchers, professionals, and students seeking to stay abreast of the latest advancements in cancer science. By addressing essential research questions and providing pathways for new therapies, CANCER continues to play a crucial role in shaping the future of oncology and improving patient outcomes.

Welcome to the International Journal of E-Health and Medical Communications, a pivotal publication designed to bridge the gap between health informatics and computer science applications. Published by IGI Global, this journal serves as a platform for innovative research and insights into e-health technologies, health communication strategies, and the evolving role of digital tools in enhancing healthcare delivery and management. With an ISSN of 1947-315X and E-ISSN 1947-3168, it caters to an audience keen on advancing the intersection of technology and health, as evidenced by its respectable standings in Scopus rankings—positioned in the 64th percentile in Health Informatics and 63rd in Computer Science Applications. Over its publication history from 2010 to 2024, the journal has consistently contributed to significant discussions and advancements within these fields, highlighted by its Q3 quartile ranking in 2023. Join a community of researchers, professionals, and students dedicated to the ongoing exploration of e-health, as we collectively navigate the complex landscape of healthcare innovation.

Digital Health is a pioneering open-access journal published by SAGE Publications Ltd, dedicated to advancing the field of health technology and its intersection with health policy, informatics, and the broader medical landscape. Since its inception in 2015, the journal has rapidly established itself as an essential resource for researchers, professionals, and students, serving as a platform for innovative research that leverages digital tools to improve health outcomes. Currently ranked in the Q2 category across four relevant domains, including Computer Science Applications and Health Informatics, it commands respect within the academic community. With its accessible framework, Digital Health facilitates the dissemination of critical findings and new methodologies that inform policy and practice. The journal’s commitment to open access promotes worldwide access and cooperation, making significant contributions to the evolving landscape of digital health.

JAMIA Open is an open-access journal dedicated to advancing the field of health informatics, published by Oxford University Press. Since its inception in 2018, the journal has provided a platform for novel research, reviews, and case studies that bridge the gap between healthcare and information technology. With an impressive impact factor and a current classification in the Q2 quartile for Health Informatics, JAMIA Open has established itself as a vital resource for researchers and practitioners alike, facilitating the dissemination of innovative findings that contribute to the evolution of healthcare systems. Based in the United States, the journal is committed to providing free and equitable access to high-quality research, thus promoting a collaborative and informed approach to tackling pressing health issues. As it continues to grow and evolve, JAMIA Open remains a cornerstone in the landscape of health informatics, appealing to a diverse audience of researchers, professionals, and students looking to inspire change in their fields.

Welcome to JCO Clinical Cancer Informatics, an esteemed journal at the forefront of the intersection between oncology and health informatics. Published by Lippincott Williams & Wilkins, this journal is dedicated to advancing the understanding and application of cancer data through innovative informatics solutions. Since its inception in 2017, JCO Clinical Cancer Informatics has established itself as a critical resource for researchers, practitioners, and students, as evidenced by its high rankings in the 2023 Scimago Quartiles—Q2 in Cancer Research and Q1 in both Health Informatics and Oncology. With a commitment to open access, this journal aims to disseminate groundbreaking research findings that enhance cancer care and inform public health strategies. Positioned in the United States, it serves as a pivotal platform for sharing knowledge and fostering collaboration within the global cancer research community.

Medical Oncology, published by Humana Press Inc, stands as a significant contributor to the field of oncology, with its long-standing commitment to disseminating research and clinical findings relevant to the treatment and management of cancer. Established in 1994 and continuing through 2024, this journal publishes insightful articles that reflect the latest advancements in cancer research, hematology, and related medical fields. With an evolving impact factor and remarkable categorizations, including Q3 in Cancer Research and Q2 in both Hematology and Oncology, Medical Oncology serves as a pivotal resource for healthcare providers, researchers, and students dedicated to improving cancer outcomes. Although it does not offer open access, the journal is widely recognized for its rigorous peer-review process and high-quality publications, making it an essential platform for sharing innovative research and critical reviews in oncology.

Current Oncology is a prominent open-access journal dedicated to the field of oncology, published by MDPI in Switzerland. With an ISSN of 1198-0052 and E-ISSN 1718-7729, this esteemed journal has been providing valuable insights since its inception in 1998 and continues to publish cutting-edge research through 2024. Recognized for its contribution to the medical community, Current Oncology holds a 2023 Q2 category rank in Oncology and is positioned at the 41st percentile among its peers in Scopus rankings. As a hub for innovation and discussion in cancer research, it offers a plethora of articles that span various aspects of oncology, making it an essential resource for researchers, professionals, and students alike. Since becoming fully open-access in 2006, it provides expanded accessibility to groundbreaking studies and findings, fostering collaboration and knowledge exchange across the global research community. With its central location in Basel, Switzerland, Current Oncology plays a pivotal role in advancing oncology's frontiers.